Somatic Symptom Scale-8 (SSS-8)
Also known as: SSS-8, Somatic Symptom Scale
The Somatic Symptom Scale-8 is a brief eight-item self-report instrument designed by Bernd Gierk and colleagues to assess the severity and burden of somatic (bodily) symptoms. Published in JAMA Internal Medicine in 2014, the SSS-8 is derived from the longer Somatic Symptom Disorder-B Criteria Scale and serves as a rapid screening tool for somatic symptom disorder and medically unexplained symptoms. It is widely used in primary care, general medicine, and psychiatry to identify patients whose physical complaints may warrant psychological or behavioral intervention.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Recommended for: primary care screening of medically unexplained symptoms; identifying patients whose somatic complaints may benefit from psychological or behavioral intervention; research on somatic symptom burden and health anxiety; assessing treatment response in somatic symptom disorder; monitoring symptom trajectory in patients with chronic medically unexplained symptoms.
Strengths & limitations
- Exceptional brevity—eight items, 2–3 minutes, highly practical for primary care screening or repeated administration
- Transdiagnostic coverage—applicable across symptom types (pain, fatigue, GI, respiratory), not tied to specific diagnosis
- Strong psychometric properties—Cronbach's alpha 0.85–0.88, test-retest reliability r = 0.78–0.86, excellent sensitivity and specificity for somatic symptom disorder (82–87%)
- Addresses psychological burden—goes beyond symptom count to assess health anxiety and life interference, capturing clinically relevant distress
- Free public domain—no licensing restrictions; available in 15+ languages
- Responsive to treatment—demonstrates change with cognitive-behavioral or interpersonal psychotherapy targeting somatic symptoms
- Does not diagnose somatic symptom disorder—elevated scores indicate somatic burden but require full psychiatric and medical evaluation for diagnosis
- Cannot replace medical workup—high SSS-8 does not exclude organic disease; medical assessment should precede or accompany psychological screening
- Limited symptom specificity—total score does not distinguish pain from fatigue from GI symptoms; item-level examination needed
- Self-report bias—vulnerable to exaggeration (health anxiety, secondary gain) or minimization (stoicism, denial); clinician judgment needed
- No assessment of health behaviors—SSS-8 does not measure avoidance, safety-seeking, or physician-shopping behaviors that maintain somatic symptoms
- Two-week recall window—may not capture episodic or seasonal symptom patterns
Frequently asked
Does a high SSS-8 score mean symptoms are 'all in my head'?
No. A high SSS-8 indicates somatic symptoms are experienced intensely and causing significant distress. Whether symptoms have organic, psychological, or mixed causes requires medical and psychiatric evaluation. High SSS-8 suggests psychological and behavioral factors may be amplifying symptom perception; this doesn't make symptoms less real.
Should I administer SSS-8 before or after medical workup?
Ideally, after medical workup. Screen for and address organic causes (infection, inflammation, endocrine dysfunction) first. If medical evaluation is negative or incomplete, SSS-8 helps identify health anxiety warranting psychological attention while medical investigation continues. Never use high SSS-8 to exclude organic disease.
How does SSS-8 relate to somatic symptom disorder (SSD) diagnosis?
SSS-8 is a screening tool for somatic symptom burden and health anxiety—key features of SSD. A high SSS-8 score (≥12) suggests SSD risk but does not diagnose it. SSD diagnosis requires DSM-5 criteria: somatic symptoms (6+ months) causing significant distress, excessive health-related thoughts/behaviors, and symptom persistence despite reassurance or negative workup.
Can I use SSS-8 to monitor treatment response?
Yes. SSS-8 is responsive to cognitive-behavioral or interpersonal therapy targeting somatic symptoms. Repeat every 4–8 weeks during treatment; a ≥50% reduction from baseline indicates meaningful improvement in symptom burden and health anxiety.
Sources
- Gierk, B., Kohlmann, S., Kroenke, K., Spangenberg, L., Zhan, Y., Scherer, M., & Herzberg, P. Y. (2014). The Somatic Symptom Scale-8 (SSS-8): a brief measure of somatic symptom burden. JAMA Internal Medicine, 174(3), 399–407. DOI: 10.1001/jamainternmed.2013.12179 ↗
- Kroenke, K., Spitzer, R. L., Williams, J. B., & Löwe, B. (2010). The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. General Hospital Psychiatry, 32(4), 345–359. DOI: 10.1016/j.genhosppsych.2010.03.006 ↗
- Toussaint, A., Murray, A. M., Voigt, K., Gierk, B., Kroenke, K., Scherer, M., & Lowe, B. (2016). Development and validation of the Somatic Symptom Disorder-B Criteria Scale (SSD-12). Psychosomatic Medicine, 78(1), 5–12. DOI: 10.1097/PSY.0000000000000240 ↗
How to cite this page
ScholarGate. (2026, June 3). Somatic Symptom Scale-8 (SSS-8). ScholarGate. https://scholargate.app/en/clinical-psychology/somatic-symptom-scale-8
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Patient Global Impression of ChangeClinical Psychology↔ compare
- Patient Health Questionnaire-9Clinical Psychology↔ compare
- Quick Inventory of Depressive SymptomatologyClinical Psychology↔ compare